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In this study we describe the first isolation of Mycobacterium triplex in Latin America. This
species causes infections in humans, with very few reports from around the world. We
isolated two sputum specimens of a patient with a 6-year history of human immunodefi-
ciency and tuberculosis treatment failure. All tests used confirmed M. triplex and the
patient responded well to drug therapy for 18 months.
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All rights reserved.Introduction clinical strains of different geographical locations in theNontuberculous mycobacteria are ubiquitous and transmit-
ted to humans through the environment from sources like
water and soil, causing infections in different areas of the
body, but mainly pulmonary, skin, soft tissue infections, and
lymphadenitis [1].
Mycobacterium triplex is a slow growing, nonpigmented,
nontuberculous mycobacterium, described in 1996 fromUnited States [2]. This species is related to Mycobacterium
simiae, Mycobacterium lentiflavum, and Mycobacterium sherrisii,
but more closely to Mycobacterium genavense [3].
Only a few cases ofM. triplex infections have been reported
in the United States and Europe. To our knowledge, this is the
first report of M. triplex infection in a country of Latin
America. This study was approved by the ENSP–Fiocruz
Committee for Ethical Research with human beings.192, Brazil.
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The patient studied was clinically, laboratorial, and radiologi-
cal assessed at diagnosis. Monthly cultures were performed to
monitor the progress of treatment in Hospital Sanato´rio
Partenon in Porto Alegre, Rio Grande do Sul state, Brazil.
Two sputum isolates were obtained according of American
Thoracic Society microbiologic criteria for nontuberculous
mycobacterial lung disease [4] and processed at the central
laboratory of Rio Grande do Sul, Brazil, in the period of
2007–2008. After growth in Lo¨wenstein–Jensen medium, the
cultures were sent to the Centro de Refereˆncia Professor He´lio
Fraga/ENSP/FIOCRUZ for identification, but the PRA-hsp65
methodology did not allow for identification at species level.
To clarify the identity and to characterize the isolates,
phenotypic and sequencing assays were performed in the
laboratory of Centro de Refereˆncia. The two isolates were des-
ignated as HF1226 and HF2396 and tested for pigment produc-
tion and growth rate at 35–37 C. The following biochemical
tests were performed: nitrate reduction, niacin production,
heat-stable catalase (68 C), arylsulfatase activity (at 3 days),
Tween 80 hydrolysis, and urease. The isolates were slow
growing and nonpigmentated. The biochemical profile was
positive for nitrate reduction, heat-stable catalase, and
urease, and negative for niacin, 3 days arylsulfatase, and
Tween 80 hydrolysis. Part of the RNA polymerase beta-
subunit gene (rpoB), the 16S–23S internal transcribed spacer,
and the 441 bp fragment of the 65 kDa heat shock protein
gene (hsp65) were sequenced using previously published
approaches [5–7].
Results and discussion
The 51-year-old Caucasian woman studied had been treated
for tuberculosis three times in the past. The patient presented
with a productive cough and night sweats and her CD4 count
was 514 cells/mL. She was being treated for human immun-
odeficiency virus with antiretroviral therapy (zidovudine,
lamivudine, and tenofovir). The sputum smear microscopy
showed acid-fast bacilli (+) in two samples. A chest X-rayFigure 1 – Phylogenetic concatenated tree using 16S rDNA, hsp6
cted using neighbor-joiningmethod and Kimura’s two-paramete
on 1000 replicates, indicated the significance of branches. Myc
M. =Mycobacterium.revealed bilateral pulmonary lesions (nodular opacities and
cavities). She was empirically prescribed amikacin, ofloxacin,
ethambutol, and clarithromycin, since there was no identifi-
cation of mycobacteria. No sensitivity test was conducted.
During follow-up, her respiratory symptoms improved and
periodic respiratory specimen cultures tested negative. She
was considered cured after 18 months of treatment.
The 16S rDNA gene was sequenced using MicroSEQ Full
Gene 16S rDNA Kit (Life Technologies, Carlsbad, CA, USA),
as indicated by the manufacturer. All the sequences were
compared on identity with the ones of the closest reference
strains using a basic local alignment search tool (BLAST)
search [8]. The sequences of reference type strains (retrieved
from GenBank) and strain HF1226 (the older of the two iso-
lates) were used to build a concatenated neighbor-joining tree
[9] using the MEGA version 6 program [10]. Comparison with
the reference strains present in GenBank through a BLAST
search showed that the 16S rDNA (accession number
KF856620), hsp65 (KF856621), and internal transcribed spacer
(KF856623) sequences of the isolates have 100% identity with
M. triplex type strain (ATCC 700071), but the rpoB (KF856622)
gene presented two mismatches when compared with
M. triplex type strain (99.72% identity). The next high similar-
ity was that of Mycobacterium florentinum type strain DSM
44852 with nine mismatches and 95.92% identity. The phylo-
genetic tree revealed that strain HF1226 was clustered (with
100% bootstrap) to the type strain of M. triplex and distinct
from other related species (Fig. 1).
All phenotypic results were the same as described for the
M. triplex type strain [2]. The molecular and phylogenetic
analysis of the two isolates from the Brazilian patient
confirmed the identification as M. triplex. BLAST analysis also
revealed that the polymorphisms identified in the rpoB gene
of these two strains had never been described, as no identical
sequence was found in the database.
M. triplex has been suggested as a cause of disease in
severely immunocompromised patients, but can also affect
immunocompetent individuals [11,12]. Symptoms and
radiological findings of the studied patient are similar to
those in previous reports. There are few reported cases of5, rpoB, and internal transcribed spacer sequences, constru-
r as the substitution model. The bootstrap values, calculated
obacterium tuberculosis sequence was used as the outgroup.
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reported as causing pulmonary infection in patients of coun-
tries such as Italy, Portugal, Ireland, and Finland [12–15]. In
the United States, a study described a case of M. triplex that
was isolated from the pericardial and peritoneal fluid of a
liver transplant patient [16]. Also, in the United States another
study identified eight M. triplex strains from clinical M. simiae
complex isolates [17]. There are extremely rare reports of
patients infected by M. triplex outside Europe and the United
States; one exception is a Nigerian human immunodeficiency
virus positive man with central nervous system involvement
[18].
The results presented in this study extend the range of
geographical distribution of M. triplex. This finding increases
the possibility of the diagnosis of new cases of M. triplex
infection in Latin America, especially in Brazil.
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